Tickerplace logo

Tickerplace

Cadrenal Therapeutics, Inc. Common Stock logo

CVKDCadrenal Therapeutics, Inc. Common Stock

CVKD Stock Price, Valuation & Chart | Cadrenal Therapeutics, Inc. Common Stock

Compare
$1.330-0.18 (-11.92%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyCVKD intrinsic valueCVKD calculated fair value vs price
OverviewFinancialsDividendsRatios

CVKD Historical price chart

CVKD Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization4.74M
PE Ratio-0.27
EPS-4.9
Trading Volume375.51K
Today's High/Low1.53/1.28
Dividend Yield0.00
52 Week High/Low14.64/1.28
Shares Outstanding3.57M
CVKD Financial Statement
CVKD Analyst ratings
CVKD Analysis & performance metrics

CVKD Company profile

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug…

CVKD Management team

Management
Quang X. PhamCEO
Chairman & Chief Executive Officer
Jeffrey ColeCOO
Chief Operating Officer
James J. Ferguson FACC, M.D.
Chief Medical Officer
Total 3 executives

CVKD Frequently asked questions

What is Cadrenal Therapeutics, Inc. Common Stock (CVKD) Stock Price?

Current stock price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock is $1.330. The stock price is -11.92% lower in the session. The intraday range can be seen from this page. Volume of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock is 375.51K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock price going up or down today?

The stock price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) can change with earnings, company news, and overall market sentiment. Cadrenal Therapeutics, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cadrenal Therapeutics, Inc. Common Stock stock expensive at its current price?

Whether Cadrenal Therapeutics, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CVKD on this page is -0.27. EPS on this page is -4.90. Compare those figures with peers and growth expectations before deciding if the current Cadrenal Therapeutics, Inc. Common Stock price is justified.

How has the stock price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) performed historically?

Historical performance for Cadrenal Therapeutics, Inc. Common Stock (CVKD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CVKD reacted to past earnings and market events.

Should I buy Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock, at this price?

Buying Cadrenal Therapeutics, Inc. Common Stock (CVKD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.